关注
Maksim Kholmatov
Maksim Kholmatov
predoctoral fellow at EMBL
在 embl.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Putting hands to rest: efficient deep CNN-RNN architecture for chemical named entity recognition with no hand-crafted rules
I Korvigo, M Holmatov, A Zaikovskii, M Skoblov
Journal of cheminformatics 10, 1-10, 2018
562018
Spectrum of APC and MUTYH germ‐line mutations in Russian patients with colorectal malignancies
GA Yanus, TA Akhapkina, AO Ivantsov, EV Preobrazhenskaya, ...
Clinical genetics 93 (5), 1015-1021, 2018
192018
Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants
NV Mitiushkina, VI Tiurin, AG Iyevleva, MM Kholmatov, EA Filippova, ...
Biochimie 154, 19-24, 2018
182018
Lack of response to vemurafenib in melanoma carrying BRAF K601E mutation
FV Moiseyenko, VV Egorenkov, MM Kramchaninov, EV Artemieva, ...
Case reports in oncology 12 (2), 339-343, 2019
152019
Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping
NV Mitiushkina, MM Kholmatov, VI Tiurin, AA Romanko, OS Yatsuk, ...
Biochimie 165, 267-274, 2019
132019
PCR-based detection of EGFR, ALK, KRAS and BRAF mutations in Russian patients with lung adenocarcinoma: a single-center experience.
NV Mitiushkina, MM Kholmatov, AR Venina, VI Tiurin, GA Yanus, ...
Neoplasma 65 (6), 972-979, 2018
122018
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal
ES Kuligina, R Meerovich, KA Zagorodnev, MM Kholmatov, TN Sokolova, ...
Cancer Genetics 256, 165-178, 2021
92021
Exome-based search for recurrent disease-causing alleles in Russian population
GA Yanus, TA Akhapkina, AJ Whitehead, IV Bizin, AG Iyevleva, ...
European journal of medical genetics 62 (7), 103656, 2019
82019
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer
FV Moiseyenko, ES Kuligina, AS Zhabina, SA Belukhin, TA Laidus, ...
International journal of clinical oncology 27 (5), 850-862, 2022
32022
1197P Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC
ES Kuligina, FV Moiseenko, SA Belukhin, TA Laidus, AS Martianov, ...
Annals of Oncology 31, S787, 2020
2020
Presence of distant metastases and disease progression but not tumor size, lymph node involvement, circadian rhythms, prior physical exercise or recent food consumption …
ES Kuligina, R Meerovich, KA Zagorodnev, MM Kholmatov, TA Laidus, ...
Cancer Research 80 (16_Supplement), 717-717, 2020
2020
Preferential expression of the affected MET allele in lung carcinomas with heterozygous MET exon 14 skipping mutations: Implications for clinical testing
E Imyanitov, N Mitiushkina, M Kholmatov, V Tiurin, A Romanko, ...
Annals of Oncology 30, v638-v639, 2019
2019
PCR-based analysis of MET exon 14 skipping mutations in Russian lung cancer patients
G Raskin, M Kholmatov, N Mitiushkina, V Tiurin, A Romanko, E Imyanitov
VIRCHOWS ARCHIV 475, S145-S145, 2019
2019
Advanced Parser for Biomedical Texts
A Karazeev, M Holmatov, A Zaikovskii, I Korvigo, M Skoblov
Moscow Conference on Computational Molecular Biology (MCCMB 2017), 137-137, 2017
2017
系统目前无法执行此操作,请稍后再试。
文章 1–14